Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

High-resolution analysis of mononuclear phagocytes reveals clinically relevant markers in human colo-rectal liver metastasis II

ABSTRACT: High-resolution analysis of mononuclear phagocytes reveals clinically relevant markers in human colo-rectal liver metastasis II

PROVIDER: PRJNA823746 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18649811.fastq.gz	Fastqsanger.gz
	SRR18649812.fastq.gz	Fastqsanger.gz
	SRR18649813.fastq.gz	Fastqsanger.gz
	SRR18649814.fastq.gz	Fastqsanger.gz
	SRR18649815.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

High-resolution analysis of mononuclear phagocytes reveals clinically relevant markers in human colo-rectal liver metastasis

Project description:Macrophages (Mf) are the most abundant mononuclear phagocytes in tumor tissues and hold promise as therapeutic targets and indicators of disease progression. In this work, we mapped by single-cell analysis the distinct Mf populations infiltrating the invasive margin and normal adjacent regions of human colo-rectal liver metastasis (CLM), and we exploited this information to identify non redundant markers with clinical relevance. Different populations were enriched in the invasive margin, including early-mature, inflammatory Mf (MoMf) expressing the monocytic markers S100A12 and SERPINB2, and a more mature population (TAMs) expressing CD68, GPNMB and TREM2. TAMs were enriched in pathways of matrix degradation, angiogenesis and lipid metabolism, similarly to dysfunctional macrophages described in other tumors. Cell-cell interaction analysis with CD8+ T cells defined opposing roles of MoMf, predicted to interact via IL-15, and TAMs, engaging T cells via IL-20 and IL-10. By multiplex immunofluorescence in CLM sections, we confirmed that SERPINB2 and GPNMB are expressed by different Mf subsets, with distinct topographical distribution and opposite association with patient clinical outcome.

2023-05-02 | GSE200068 | GEO

High-resolution analysis of mononuclear phagocytes reveals clinically relevant markers in human colo-rectal liver metastasis II

2023-05-02 | GSE200253 | GEO

High-resolution analysis of mononuclear phagocytes reveals clinically relevant markers in human colo-rectal liver metastasis

Project description:High-resolution analysis of mononuclear phagocytes reveals clinically relevant markers in human colo-rectal liver metastasis

| PRJNA822820 | ENA

High-resolution analysis of mononuclear phagocytes reveals clinically relevant markers in human colo-rectal liver metastasis - Visium Spatial Transcriptomics

2024-01-29 | GSE254364 | GEO

High-resolution analysis of mononuclear phagocytes reveals clinically relevant markers in human colo-rectal liver metastasis - Visium Spatial Transcriptomics

Project description:High-resolution analysis of mononuclear phagocytes reveals clinically relevant markers in human colo-rectal liver metastasis - Visium Spatial Transcriptomics

| PRJNA1070252 | ENA

Whole Metagenome Sequencing of colo-rectal cancer in Lynch Syndrome Patients

Project description:Whole Metagenome Sequencing of colo-rectal cancer in Lynch Syndrome Patients

| PRJEB70916 | ENA

Liver Transplantation and Metastatic Colo-rectal Cancer.

Project description:Survival of colo-rectal cancer patients after liver transplantation.

| 2026591 | ecrin-mdr-crc

Predicting multi-class responses to preoperative chemoradiotherapy in rectal patients

Project description:The treatment strategy of rectal cancer has substantially changed in recent decades. Historically postoperative chemoradiotherapy (CRT) was considered to be the first-line therapy for stage II and III rectal cancers. However, the preoperative CRT is now considered to be the optimal therapy regimen for locally advanced rectal ancer due to its improved local control, reduced toxicity, and increased rate of sphincter preservation. Our study established a clinically practical multi-class prediction model by adopting a novel strategy that applies two separate prediction models (MI and TO predictor) sequentially to a patient to predict the response. For promising clinical practice, we validated our model in a published dataset, which is completely independent dataset from ours. This study suggests a clinically plausible prediction model that correctly infers the preoperative CRT response of patients with high accuracy based on 163 gene signatures we identified. Total RNAs were isolated from primary rectal tumor tissues of 69 patients who underwent chemoradiation therapy (CRT). These patients are classified into four different CRT responses: minimal response (MI), moderate response (MO), near total response (NT) and total response (TO). All the RNAs were subjected to microarray analysis using Affymetrix GenChip arrays.

2013-05-14 | E-GEOD-46862 | biostudies-arrayexpress

Predicting multi-class responses to preoperative chemoradiotherapy in rectal patients

2013-05-14 | GSE46862 | GEO

COLO 320 (Human colorectal cancer cell line) xenograft: Control (Xenograft without rat mesenchymal stem cells (MSCs)) vs Xenograft with rat MSCs

Project description:Transcriptional profiling of COLO 320 xenograft tumor cells comparing control COLO 320 xenograft without co-implanted rat MSCs with COLO 320 xenograft with co-implanted rat MSCs. The latter makes co-implanted MSCs visualization possible by using MSCs labeled by GFP under FACS and single cell microscopy.

2014-11-18 | GSE29389 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data